These observations indicate that the activation levels of IFNγ signaling in AML cells are associated with distinct cellular states and hierarchies, and that disparate regulons of IFNγ signaling characterize various patient subgroups. The gene discussed is IFNG; the disease is acute myeloid leukemia.